Novus Therapeutics (NVUS) Stock Rating Upgraded by ValuEngine - Fairfield Current

Novus Therapeutics (NVUS) Stock Rating Upgraded by ValuEngine  Fairfield Current

Novus Therapeutics (NASDAQ:NVUS) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Monday. Separately ...



Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

Sarcoidosis: Causes, Symptoms, Diagnosis & Treatment